Table 1.
Expression levels of ANXA7 and SODD mRNA in each experimental group (X ± S)
|
| ||||
|---|---|---|---|---|
| Group | GAPDH OD value | Target gene OD value | IOD value (GAPDH OD value/target gene OD value) | Set irrelevant sequences to 1, normalize |
|
| ||||
| ANXA7 | ||||
| PANXA7 unrelated sequence group | 70.24 | 65.45 | 0.93 | |
| Hca-P group | 76.18 | 61.79 | 0.81 | 0.87 |
| PANXA7 down-regulated group | 69.31 | 14.85 | 0.21* | 0.23 |
| SODD | ||||
| PANXA7 unrelated sequence group | 70.24 | 76.32 | 1.09 | |
| Hca-P group | 76.18 | 80.84 | 1.06 | 0.98 |
| PANXA7 down-regulated group | 69.31 | 21.34 | 0.31* | 0.28 |
|
| ||||
SODD; Suppressor of death domains, OD; Optical density, IOD; Integrated optical density, and *; P<0.05, compared to the unrelated sequence group.